Pedro Coelho

Pedro Coelho is a visionary leader and the Founder and CEO of Biorce, a pioneering health AI company dedicated to accelerating and optimizing patient access to life-changing treatments. Drawing upon years of experience in the life sciences consulting sector, Pedro recognized critical industry inefficiencies that hindered patient care. In 2024, he launched Biorce, embodying the fusion of "Biology" and "Force," to revolutionize the healthcare landscape. Prior to Biorce, Pedro served as Senior Vice President at Talentmark, where he established TMFS, a specialized CRO focused on Oncology & Cell and Gene Therapy. His career also includes significant leadership roles in business development and commercial strategy, notably as Chief Commercial Officer at Konspol Holding. Pedro holds executive education credentials from Harvard Medical School and the University of Pennsylvania, complementing his Summa Cum Laude undergraduate degree in Business Administration from EU Business School and his top 2% worldwide International Baccalaureate in Sciences.